Adult respiratory distress syndrome: a disorder in need of improved outcome (Q41333907)

29 September 2017

1 reference

title

Adult respiratory distress syndrome: a disorder in need of improved outcome (English)

1 reference

29 September 2017

Brandstetter RD

1

1 reference

29 September 2017

Sharma KC

2

1 reference

29 September 2017

DellaBadia M

3

1 reference

29 September 2017

Cabreros LJ

4

1 reference

29 September 2017

Kabinoff GS

5

1 reference

29 September 2017

publication date

1 January 1997

1 reference

29 September 2017

1 reference

29 September 2017

volume

26

1 reference

29 September 2017

issue

1

1 reference

29 September 2017

page(s)

3-14

1 reference

Physiologists look at the problem. Panel discussion

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Shock lung: a distinctive nonentity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Acute respiratory distress in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

The adult respiratory distress syndrome. Clinical features, factors influencing prognosis and principles of management.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

An expanded definition of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Treatment of sepsis and septic shock: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Sepsis trials. Intersection of investigation, regulation, funding, and practice

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Establishing the relative accuracy of three new definitions of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Survival in patients with severe adult respiratory distress syndrome treated with high-level positive end-expiratory pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

The influence of PEEP on survival of patients in respiratory failure: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Should the lung be rested or recruited? The Charybdis and Scylla of ventilator management

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Use of ultrahigh frequency ventilation in patients with ARDS. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Should inverse ratio ventilation be used in adult respiratory distress syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Increased survival of ARDS patients with severe hypoxemia (ECMO criteria)

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

New modes of mechanical ventilation for ARDS. How should they be evaluated?

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Ventilators. Back to the future

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

High-dose corticosteroids in patients with the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Studies on the role of tumor necrosis factor in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Immunologic therapy for ARDS, septic shock, and multiple-organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Vascular endothelial cells synthesize nitric oxide from L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Inhaled nitric oxide for the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Efficacy of inhaled nitric oxide in patients with severe ARDS

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Adult respiratory distress syndrome: risk with common predispositions

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Clinical predictors of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Prospective validation of an acute respiratory distress syndrome predictive score

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

The oxygen delivery/consumption controversy. Approaches to management of the critically ill.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Sedation, analgesia, and paralysis in the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Adult respiratory distress syndrome--an update.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Recovery of function in survivors of the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Prostacyclin and thromboxane A2 formation is increased in human sepsis syndrome. Effects of cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Tissue destruction by neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Prolonged paralysis after treatment with neuromuscular junction blocking agents

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Role of early enteral feeding and acute starvation on postburn bacterial translocation and host defense: prospective, randomized trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Aerosolised prostacyclin in adult respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Incidence and mortality of adult respiratory distress syndrome: a prospective analysis from a large metropolitan hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Physiology of aging related to outcome in the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Multiple organ system failure and infection in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Adult respiratory distress syndrome. Sequence and importance of development of multiple organ failure. The Prostaglandin E1 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Acute respiratory failure: mortality associated with underlying disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

Pulmonary Function following Adult Respiratory Distress Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-9563%2897%2990004-2

7 January 2021

10.1016/S0147-9563(97)90004-2

Identifiers

DOI

1 reference

29 September 2017

1 reference